Trial Profile
A Single Center Randomized Open-Label Two Arm Crossover Study of Subject Productivity Improvement and Satisfaction With Migraine Treatment Using Treximet vs Usual Triptan
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 27 Jun 2023
Price :
$35
*
At a glance
- Drugs Naproxen sodium/sumatriptan (Primary) ; Tryptamines
- Indications Migraine
- Focus Therapeutic Use
- Acronyms TRXvUsualTrptn
- 10 Aug 2016 Status changed from recruiting to completed.
- 05 Feb 2015 Planned primary completion date changed from 1 Dec 2014 to 1 Dec 2016 as reported by ClinicalTrials.gov record.
- 23 Jun 2014 Planned primary completion date changed from 1 Jun 2014 to 1 Dec 2014 as reported by ClinicalTrials.gov record.